Cosmo Pharmaceuticals N.V. (SWX:COPN)

Cosmo Pharmaceuticals Revenue

In the year 2025, Cosmo Pharmaceuticals had annual revenue of 104.17M EUR, down -60.95%. Cosmo Pharmaceuticals had revenue of 52.45M in the half year ending December 31, 2025, with 6.79% growth.

• Revenue: 104.17M EUR
• Revenue Growth: -60.95%
• P/S Ratio: 15.07
• Revenue / Employee: 313.78K EUR
• Employees: 332
• Market Cap: 1.46B CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	104.17M	-162.61M	-60.95%
Dec 31, 2024	266.79M	174.01M	187.55%
Dec 31, 2023	92.78M	-9.31M	-9.12%
Dec 31, 2022	102.09M	37.02M	56.88%
Dec 31, 2021	65.07M	4.13M	6.77%